Neal B, MacMahon S, Chapman N; Blood Pressure Lowering Treatment Trialists Collaboration. Effects of ACE inhibitors, cal- cium antagonists, and other blood-pressure-lowering drugs: results of prospectively designed overviews of randomized trials: Blood Pressure Lowering Treatment Trialists Collaboration. Lancet. 2000;356:1955 1964. 14. van Bemmel T, Gussekloo J, Westendorp RGJ, Blauw GJ. In a population- based prospective study, no association between high blood pressure and mortality after age 85 years. J Hypertens. 2006;24:287 292. 15. Beckett NS, Peters R, Fletcher AE, Staessen JA, Liu L, Dumitrascu D, Stoyanovsky V, Antikainen RL, NikitinY, Anderson C, Belhani A, Forette F, Rajkumar C, Thijs L, Banya W, Bulpitt CJ; HYVET Study Group. Treatment of hypertension in patients 80 years of age or older. N Engl J Med. 2008;358:1887 1898. 16. Yusuf S, Sleight P, Pogue J, Bosch J, Davies R, Dagenais G. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular C. Venkata S. Ram Texas Blood Pressure Institute, Dallas, TX; MediCiti Medical College/Hospitals, Hyderabad/India None None None None None None None Denise Simons-Morton NHLBI None None None None None None None Robert C. Touchon University Physicians and Surgeons, Joan C. Edwards School of Medicine, Marshall University, Huntington, WV None None None None None None None Thad F. Waites Hattiesburg Clinic, Hattiesburg, MS None None None None None None None Howard S. Weintraub New York University Medical Center None None AstraZeneca ; Daiichi Sankyo*; Takeda ; Abbott ; Kowa*; Novartis None None None None This table represents the relationships of reviewers that may be perceived as actual or reasonably perceived conflicts of interest as reported on the Disclosure Questionnaire, which all reviewers are required to complete and submit. 